Kim, S.-H., Menon, H., Jootar, S., Saikia, T., Kwak, J.-Y., Sohn, S.-K., Park, J. S., Jeong, S. H., Kim, H. J., Kim, Y.-K., Oh, S. J., Kim, H., Zang, D. Y., Chung, J. S., Shin, H. J., Do, Y. R., Kim, J.-A., Kim, D.-Y., Choi, C. W., Park, S., Park, H. L., Lee, G. Y., Cho, D. J., Shin, J. S. and Kim, D.-W. (2014) “Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors”, Haematologica. Pavia, Italy, 99(7), pp. 1191-1196. doi: 10.3324/haematol.2013.096776.